Ran Li
Changchun, 130033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Retraction notice to "Angelica polysaccharide protects PC-12 cells from lipopolysaccharide-induced injury via down-regulating microRNA-223" [Biomed. Pharmacother. 108 (2018) 1320-1327]".
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 01, 2023
Retraction notice to "Knockdown of ANRIL aggravates H2O2-induced injury in PC-12 cells by targeting microRNA-125a" [Biomed. Pharmacother. 92 (2017) 952-961].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 11, 2022
LINC01116 Promotes Doxorubicin Resistance in Osteosarcoma by Epigenetically Silencing miR-424-5p and Inducing Epithelial-Mesenchymal Transition.
Journal: Frontiers in pharmacology
Published: November 22, 2020
MiR-23b-3p promotes postmenopausal osteoporosis by targeting MRC2 and regulating the Wnt/β-catenin signaling pathway.
Journal: Journal of pharmacological sciences
Published: September 28, 2020
microRNA-125b and its downstream Smurf1/KLF2/ATF2 axis as important promoters on neurological function recovery in rats with spinal cord injury.
Journal: Journal of cellular and molecular medicine
Published: July 10, 2020
MicroRNA-145-Mediated KDM6A Downregulation Enhances Neural Repair after Spinal Cord Injury via the NOTCH2/Abcb1a Axis.
Journal: Oxidative medicine and cellular longevity
Published: June 19, 2020
RETRACTED: Angelica polysaccharide protects PC-12 cells from lipopolysaccharide-induced injury via down-regulating microRNA-223.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 13, 2018
Knockdown of ANRIL aggravates H2O2-induced injury in PC-12 cells by targeting microRNA-125a.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 03, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026